THE DEAL, AT A GLANCE
From the announcementMaybio
01What happenedMaybio raised $4.5M Series B, announced 2026-09-17From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Why it mattersMaybio's $4.5M Series B is a small Healthcare & Life Sciences capital-flow event for human-derived ECM materials, positioned below most tracked sector rounds at the 10th…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Maybio · Financing Record
Explore source-linked visual explanations for Maybio. Unsupported claims are withheld while source review continues.
Record 12504 · Recorded date: 2026-09-17
Explore company records →